Effective February 13, 2013, the Board of Directors of Myrexis, Inc. appointed Steven D. Scheiwe and Michael C. Pearce to the Board. Mr. Scheiwe was appointed as a Class I director with a term expiring at the 2013 annual meeting of stockholders. Mr. Pearce was appointed as a Class III director with a term expiring at the 2012 annual meeting of stockholders. Mr. Scheiwe has been the President of Ontrac Advisors, Inc. and Mr. Pearce has served as Chairman of Pernix Therapeutics Holdings.